ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2024

A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin.

Aditi Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.